Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Multicenter Survey of the Indications for Esophagogastroduodenoscopy (EGD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03603093
Recruitment Status : Completed
First Posted : July 27, 2018
Last Update Posted : November 18, 2021
Sponsor:
Collaborators:
Hunan Children's Hospital
Wuhan Children's Hospitall
Xiamen Children's Hospital
Henan Provincial People's Hospital
Information provided by (Responsible Party):
Ying HUANG, Children's Hospital of Fudan University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Esophagogastroduodenoscopy (EGD) become more and more common in diagnosing gastroenterology diseases. The investigators want to find which symptoms can support for positive endoscopic findings through this multicenter study.

Condition or disease
Digestive System Abnormalities Endoscopy

Detailed Description:
Esophagogastroduodenoscopy (EGD) become more and more common in diagnosing gastroenterology diseases. And there are indications for EGD. Here, investigators want to find which symptoms can strongly support for positive endoscopy findings. So, investigators design the study to record the symptoms in detail and diagnosis, and then analysis symptoms and the rate of endoscopic findings.
Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 2287 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Children's Hospital of Fudan University
Actual Study Start Date : December 24, 2018
Actual Primary Completion Date : August 30, 2019
Actual Study Completion Date : October 30, 2019
Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Quantities of every indications for esophagogastroduodenoscopic procedures collected from questionaire finished by clinical doctor [ Time Frame: from August 15th to October 15th in 2018 ]
    Indications for esophagogastroduodenoscopic procedures were collected through questionaire, including abdominal pain, vomiting, and so on.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All of the patients need esophagogastroduodenoscopic procedures
Criteria

Inclusion Criteria:

  • All of the patients need esophagogastroduodenoscopic procedures

Exclusion Criteria:

  • Patients whose parents reject to provide information for study
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03603093


Locations
Layout table for location information
China
Children's hospital of Fudan Universtity
Shanghai, China
Sponsors and Collaborators
Children's Hospital of Fudan University
Hunan Children's Hospital
Wuhan Children's Hospitall
Xiamen Children's Hospital
Henan Provincial People's Hospital
Investigators
Layout table for investigator information
Study Director: Ying Huang, doctor Children's Hospital of Fudan University
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Ying HUANG, The director of gastroenterology of Children's Hospital of Fudan University, Children's Hospital of Fudan University
ClinicalTrials.gov Identifier: NCT03603093    
Other Study ID Numbers: fudanU-E2
First Posted: July 27, 2018    Key Record Dates
Last Update Posted: November 18, 2021
Last Verified: November 2021

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Ying HUANG, Children's Hospital of Fudan University:
Esophagogastroduodenoscopy
Paediatric
Additional relevant MeSH terms:
Layout table for MeSH terms
Digestive System Abnormalities
Congenital Abnormalities
Digestive System Diseases